DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

KOL Analysis

Formerly known as Activate Networks, our visualization solutions allow communication of complex data integration.  These solutions provide the level of precision necessary to achieve the business objectives of identifying both regional and local HCP leaders.  This includes data reflecting a physician's expertise (KOL qualifications), as well as clinical behaviors, which enables effective targeting based on customers' current needs.

We have the most comprehensive data sources and proven analytics in the industry

Identify the right leader for the right role

Market Assessment

Using the most comprehensive secondary data sources and proven analytics in the industry, our KOL identification solutions help you identify the right leader, for the right role, across the entire product lifecycle.

Talk to us

Market Access

Providing pinpoint analyses that translate account strategies of ACOS / IDNS into actionable sales targeting activities including how to understand the impact of ACO influence on physician choice and what drive a switch in physician behavior.

Talk to us

Brand Commercialization

Magnifying your brand’s reach and commercial targeting effectiveness with physician network analytics, Activate Network Influencer identifies and rank key action leaders by therapeutic area in each community (the doctors who drive brand decision-making) and link them to colleagues whose brand decisions they influence.

Talk to us

 

KOL_computer

 

Activate Networks

Magnify your brand’s reach and targeting effectiveness with physician network analytics

  • Identification of Communities of Practice and quantify physician influence
  • National and international targeting for promotion
  • Expert and identification and segmentation tailored to your use case
  • Event audience optimization based on their connections to the speaker

Our latest thoughts and commentary

 

Latest articles

JAK inhibitors in IBD

On the Way to Becoming JAKs of All Trades On July 13th, 2017 Pfizer announced that its application for approval in ulcerative...

More Articles

In the news
News articles citing DRG analysts data.
More News